Limited and External Funding Opportunity Announcements

 

Active Internal Calls for Limited Submission Nominations 


Greenwall Faculty Scholars Program

Applications due August 30th 

Vanderbilt may nominate up to two faculty for the Greenwall Faculty Scholars Program in Bioethics. These three-year career development awards enable junior faculty members to carry out innovative bioethics research that goes beyond current work in bioethics to help resolve pressing ethical issues in clinical care, biomedical research and public policy. Priority will be given to applicants whose research addresses innovative and emerging topics. The award supports 50 percent of a scholar’s salary plus benefits for three years.

Eligibility:

  • Applicants must be junior faculty members holding at least a 60 percent appointment in a tenure-track position.
  • Priority will be given to applicants who have not yet been considered for tenure, who have not received a comparable career development award, and whose work will have an impact on public policy, biomedical research or clinical practice.

Guidelines:

Greenwall Faculty Scholars will be selected based on:

  • their achievements;
  • the strength of their research project;
  • commitment to the field of bioethics; and
  • support from Vanderbilt.

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in order, in a single PDF file) to LSO@vanderbilt.edu  by 5 p.m. on August 30, 2017

1.      Brief (2 page maximum) research plan including summary budget;

2.      Brief statement of support from department chair/center director;

3.      CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email.

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominee will submit a letter of intent to the Foundation by the November 1, 2017 deadline. A subset of applicants will then be invited to submit full proposals.

Visit the foundation’s website for full application guidelines. If you have any questions about this opportunity, please contact: Amy Martinez (615-875-0740), Program Manager in the Office of Research.


2018 Rita Allen Foundation Scholars Award

Applications due September 15th 

Vanderbilt (VU and VUMC collaboratively) may nominate one candidate for the Rita Allen Foundation Scholars Award Program for 2018. The foundation supports early-career biomedical scholars doing pioneering research. This award typically provides $550,000 over five years for young investigators involved in research in the cure and treatment of diseases in the fields of cancer, immunology, and neuroscience.

Eligibility Criteria:

Candidates should be independent investigators in the early stages (preferably in the first 3 years) of a tenure track faculty appointment
Scholars may not accept a faculty development award of more than $200,000 from another funding organization for the first year of the Rita Allen award.

Guidelines for Selection:

The foundation seeks candidates of extraordinary promise with recent appointments at the faculty level and projects with above-average risk that break new ground and challenge the status quo. Rita Allen Foundation Scholars are distinguished by their bold approaches to basic scientific questions that address problems of global concern, as well as their potential for learning, leadership and collaboration.

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on Friday, September 15, 2017:

  1. Brief (2 page maximum) research plan including summary budget;
  2. Brief statement of support from department chair/center director;
  3. CV or NIH Biosketch

Submissions should reference the program name in the subject line of the email.

Once received, all proposals will be forwarded to an internal review committee that will choose the final nominee. The chosen nominee will submit a letter of inquiry to the Foundation by the December 8, 2017 deadline, and a full application is due on January 19, 2018.

Visit the foundation’s website for full eligibility and application guidelines.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2018 Blavatnik National Awards for Young Scientists – Life Sciences Category

Vanderbilt (VU and VUMC collaboratively) may nominate one promising investigator with early career success in Life Sciences for the Blavatnik National Awards for Young Scientists. The awards honor exceptional young scientists by celebrating their extraordinary achievements, recognizing their inspiring promise, and accelerating their innovations. Awardees will receive $250,000 in unrestricted funds

Eligibility Criteria:

Guidelines for Selection:

Each nominee and their body of work will be evaluated based on the quality of their research, the impact on their respective field, the novelty of their ideas and methods, and the potential they show for future contributions to science.

Anyone interested in being considered as Vanderbilt’s nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on Wednesday, September 20, 2017:

  1. Brief (2 page maximum) research plan including summary budget;
  2. Brief statement of support from department chair/center director;
  3. CV or NIH Biosketch​

Visit the foundation’s website for full eligibility and application guidelines.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.

 

 


Active Internal Calls for NON-Limited External Nominations 


Beckman Young Investigators Program

Applications due August 14th 

The Beckman Young Investigator (BYI) Program provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences, particularly to foster the invention of methods, instruments and materials that will open up new avenues of research in science.

Guidelines:

  • Projects proposed for the BYI program should be truly innovative, high-risk, and show promise for contributing to significant advances in chemistry and the life sciences. They should represent a departure from current research directions rather than an extension or expansion of existing programs. Proposed research that cuts across traditional boundaries of scientific disciplines is encouraged. Proposals that open new avenues of research in chemistry and life sciences by fostering the invention of methods, instruments and materials will be given additional consideration.
  • The BYI program funds promising young scientists early in their careers who have not yet received a major award from another organization. Proposals that already have substantial funding will not be considered for the BYI award (see eligibility for more information).
  • Projects are normally funded for a period of four years. Grants are in the range of $600,000 over the term of the project, contingent upon demonstrated progress after the second year of the award.
  • The Foundation does not provide for overhead or for indirect costs.

Eligibility:

  • The BYI program is open to those within the first three years of a tenure-track position, or an equivalent independent research appointment, at a United States academic or non-profit institution that conducts research in chemical and life sciences. Tenure Track Start Date must be after: 8/14/2014
  • Candidates must be citizens or permanent residents of the United States at the time of application. Persons who have applied for permanent residency but have not received their government documentation by the time of application are not eligible.
  • No individual may apply for a Beckman Young Investigator award more than two times.
  • Investigators can have no more than $225,000 in direct, annualized external funding grants during any BYI Program Year (Aug-July) at time of application. Start-up funds, department-wide instrumentation grants, and "Transition" grants (such as NIH K99/R00) are not counted toward this total.

Visit the foundation's website for full application guidelines. Interested applicants, please contact Adele White in Corporate and Foundation Relations.


ASCI's 2018 Harrington Prize

Applications due August 29th 

The Harrington Prize for Innovation in Medicine, presented by the American Society for Clinical Investigation and the Harrington Discovery Institute at University Hospitals – part of The Harrington Project for Discovery & Development – honors a physician-scientist who has moved science forward with notable achievements in innovation, creativity and potential for clinical application.

This annual prize includes:

  • An unrestricted $20,000 honorarium
  • The Harrington Prize Lecture, delivered at the 2018 AAP/ASCI/APSA Joint Meeting
  • Participation at the Harrington Discovery Institute Annual Symposium
  • A personal essay, published in the Journal of Clinical Investigation 

Eligibility Criteria

  • Must hold an MD or equivalent degree
  • Need not be an ASCI member
  • No age or citizenship requirement
  • Self-nomination is not permitted
  • Must be available to deliver a lecture at the AAP-ASCI-APSA Joint Meeting
  • Must submit a personal essay for publication in the Journal of Clinical Investigation

The Federation of American Societies for Experimental Biology (FASEB)'s BioArt competition

Submissions due August 31st 

The Federation of American Societies for Experimental Biology (FASEB) announces its sixth annual BioArt competition. Help celebrate the artistic side of science by sharing a glimpse into your cutting-edge research!

About BioArt

Each day, scientific investigators produce thousands of images and videos as part of their research. However, only a few are seen outside the laboratory. Through the BioArt competition, FASEB aims to share the beauty and excitement of biological research with the public. Past winning images have been displayed at the National Institutes of Health and other venues!

Entries are welcome from individuals and research teams that either receive U.S. federal funding or include at least one member of a FASEB society. Submissions should be products of a research project. 

New Image Category

New to this competition cycle is an image category for 3D printing. Through this special focus, FASEB hopes to highlight the many different applications of this technology in biological research. Winners will be selected from this new category as well as from the contest’s long-standing image and video categories.

More Information and Resources

For more information, visit the BioArt website or email the BioArt team at BioArt@faseb.org


Concern Foundation's CONquer canCER Now Award

LOIs due September 7, 2017

The Conquer Cancer Now Award is a $60,000 grant given to young and innovative cancer researchers focused on cancer genetics, cancer biology and cancer immunology. Approximately 20 researchers receive a $60,000 Conquer Cancer Now Award per year for the two-year grant cycle. The Concern Foundation is now accepting LOI's through September 7th, 2017.

ELIGIBILITY 

Grants are awarded to independent investigators who are at the start of their scientific career (i.e., junior faculty) and are at the level of Assistant Professor (or equivalent with explanation). A letter from the applicant's Department Chair is required and should attest to

  • the applicant's faculty status
  • the applicant's status as an independent investigator
  • institutional support in terms of stand-alone laboratory space and startup funds
  • percent protected time devoted to research as junior faculty. 

This letter needs to accompany the initial Letter of Intent and (if selected) also uploaded with the full proposal. 

Priority is given to proposals from independent investigators who have yet to obtain significant funding for their work. Applicant who is PI on an existing R01 or equivalent is not eligible. Applicant who is notified prior to the full Concern grant submission deadline of a clearly fundable score on an R01 or equivalent grant-in-review where he/she is PI is also not eligible. However, a submitted R01 that has not yet been reviewed at the time of Concern grant submission is eligible. If its score is not clearly fundable in this interim period, contact Concern to determine eligibility. 

Applicants must list all current and pending support from other funding sources, noting any budgetary or scientific overlap. This includes funding from all years of multi-year grants. This information will be requested with the initial LOI and will need to be updated with the full grant application. 

Concern Foundation accepts grant applications from institutions in the United States and abroad. U.S. citizenship is not a requirement. 

Applicants at governmental agencies are not eligible. 

AWARD TERMS 

The total grant amount for a Conquer Cancer Now Award is $60,000 per year for a maximum of two years. A second year of funding is not guaranteed and is based on evidence of sufficient progress based on the required progress report, availability of funds, and approval of the Concern Foundation Executive Board. Grants are disbursed in quarterly installments. 

Please visit the foundation site for additional details.


Gilead Sciences Research Scholars Program in Hematology/Oncology

Applications due September 8, 2017

The program is designed to support innovative translational research projects in hematology/oncology, with a focus on hematologic malignancies, that can be either based around a clinical trial with strong correlative science or laboratory investigation.

Awards granted under the program may not be duplicative of funding from institutional or hospital, other governmental, non-governmental, or industry sources. Applicants seeking an award for research projects that are currently receiving or may receive partial funding from other sources are required to submit appropriate evidence, including budget information related to the other sources, to demonstrate that there is no direct overlap in funding.

This award is intended for junior faculty who are in the early stages of their career and are planning to become independent investigators.

Applicants must meet the following requirements:

  • Hold an MD, DO, PhD, or equivalent degree at time of award
  • Be within 5 years of initial faculty appointment in association with an academic research institution in the United States or Canada at the time of application
  • Have a strong career interest in hematology/oncology, with a focus on hematologic malignancies
  • Have a research mentor with extensive experience in the field of hematology/oncology, with a focus on hematologic malignancies
  • Be able to devote at least 50% of professional time to research (versus administrative, patient care, or teaching responsibilities)
  • Be able to complete the proposed research within the 2-year award period, providing evidence (manuscript, presentation, or abstracts) for future research projects

Citizenship

An applicant must be a citizen or permanent resident of the United States or Canada or hold a temporary nonimmigrant visa. This visa must be valid for the two-year award period (January 2, 2018 – December 31, 2019).

Please visit the program website for more information.


Lung Cancer Foundation of America (LCFA) & the International Association for the Study of Lung Cancer's (IASLC) Lori Monroe Scholarship in Translational Lung Cancer Research

Applications due September 15th

This joint LCFA/IASLC initiative will award:

  • 2 Lung Cancer Research Grants
  • $200,000 each grant
  • Over 2 years

Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC) seek applications for the Lori Monroe Scholarship in Lung Cancer Research Awards.

Applications addressing the following research areas will be given priority:

  • Facilitating the collaboration, information-sharing and interaction between basic researchers and clinical investigators with the goal of expediting and translating results of scientific investigation into clinical practice to reduce the burden of lung cancer; or
  • Exploring innovative models of lung cancer care delivery; or
  • Exploring the etiologies of lung cancer in the never smoker population.

The objective of this Award is to support research that improves the care of individuals with lung cancers and to reduce the burden of these diseases. Examples include studies:

  • designed to define the molecular bases of lung cancer risk assessment;
  • to improve molecular diagnostic studies designed to detect the lung cancer early and guide curative-intent therapy;
  • predictive features guiding the use of targeted or immune oncology therapy to reduce recurrence after standard curative-intent strategies in early stage disease;
  • or to improve the outcomes or cure patients with metastatic lung cancer. Studies designed to facilitate care by minimizing treatment side effects or illuminating the causes of nonsmoking related lung cancer are encouraged, as well.

For more information, please visit the website. 


AAAS's Sartorius & Science Prize for Regenerative Medicine & Cell Therapy

Submissions due October 1st 

The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is an annual prize geared towards researchers focused on basic or translational research that advances regenerative medicine and cell therapy. Established in 2017, the prize is awarded for outstanding research performed by the applicant and as a mutual endeavour to raise awareness for the field and its fundamental significance for our future.

The winner of the Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is awarded US$25,000 and a publication of his or her essay in Science. This Grand Prize essay and those of up to three runners-up are also published on Science Online. The winner and the runners-up are invited to the award ceremony. Furthermore, a 5-year AAAS membership and online subscription to Science, accompanied by attractive product packages from Sartorius, are awarded!

Awarded fields: Entries can be made in the fields of regenerative medicine, cell therapy, gene therapy, immunotherapy as well as materials and tissue engineering.

Eligibility: Every individual scientist who received his or her PhD|MD within the past 10 years may apply.

Required documents: Please submit a 1,000-word essay describing your research and its implications for regenerative medicine and cell immunotherapy as well as supporting documents.


Kenneth Rainin Foundation Synergy Award

Proposals due October 2nd 

This grant funds groundbreaking or unconventional methodologies, whose risky outlook is justified by the possibility of a major breakthrough for Inflammatory Bowel Disease (IBD). The spirit of this award is to forge partnerships and collaborations in the field of IBD research.

Synergy Award Details

  • Grant Amount: $100,000 USD in research support to each investigator on the team, up to a total of $300,000 USD. Funding is for one year.
  • Proposals Accepted Online: June 2–October 2. Applications must demonstrate that the end product of the proposed research could not be achieved without collaboration.
  • Eligibility, Budget Guidelines & How to Apply: krfoundation.org/synergy-award

Basic Science: If your research proposal is rooted in basic science, we encourage you to collaborate with investigators who can further the potential for translation of your ideas and findings.

Translational Science: If your research proposal is translational by nature, we encourage you to identify industry and clinical partners to assist in propelling your research toward clinical study.

Clinical Science: If you are looking to submit a clinical research proposal, we encourage you to collaborate with individuals who could facilitate potential clinical implementation.


Berliner Institut Für Gesundheits Forschung's Excellence Award for Sex and Gender Aspects in Health Research

Applications due October 15th 

BIH in cooperation with the Institute of Gender in Medicine (GiM) announces the “BIH Excellence Award for Sex and Gender Aspects in Health Research”. The award aims to bring more visibility to sex and gender issues in translational research. It recognizes research excellence among renowned scientists working in the field of basic and/or clinical biomedical research with a focus on sex and gender aspects.

Eligibility

To be eligible for participation in this competition, applicants must:

  • be a renowned scientist in the field of basic or clinical biomedical research
  • have made significant contributions to translational research with high relevance to the mission and strategy of BIH
  • have a focus on sex and gender aspects in their research, which means, that sex and/or gender must be an integral aspect of the applicant’s research approach and design
  • develop and provide a concise research program proposal for a visiting fellowship in Berlin that is of strategic relevance to BIH and has a focus on sex and/or gender aspects in research

How to Apply

Applications for the BIH Award must be submitted electronically via the BIH application portal at https://portal.bihealth.de/portal/SitePages/Portal.aspx
(We are sorry to announce that we have technical problems with the portal at the moment, but it should work within the next days; the latest Thursday July 20, 2017).

Please provide the following documents as a single PDF upload:

  • CV including the 5–10 most important publications
  • Motivation letter describing your achievements and the impact of those achievements in the field of translational research with a focus on sex and gender aspects
  • Exposé of the planned cooperation with scientists in Berlin and the planned research program
  • 2 reference letters

For more information concerning the Einstein BIH Visiting Fellowship and the BIH Visiting Professor please visit this page.


BrightFocus Foundation Alzheimer's Disease Research Grants

Applications due October 18, 2017

The BrightFocus Foundation (BrightFocus) awards grants for basic research on the causes of and treatments for Alzheimer’s disease, macular degeneration, and glaucoma. This Standard Award falls within the Alzheimer’s Disease Research (ADR) program. The BrightFocus programs are designed to provide initial funding for highly innovative experimental ideas, including interdisciplinary investigations that may apply to two or three of the BrightFocus disease interests.

Award details

The Alzheimer’s Disease Research Standard Award provides significant funding for researchers who have already generated some amount of preliminary data, but are often required to demonstrate additional, significant progress before they can apply to governmental or industrial funding agencies.

Award Amount: $300,000
Duration: 3 years

Although preliminary data is required for all awards, BrightFocus considers its awards as “pilot funding”. BrightFocus prefers to fund innovative proposals for which there are few alternative sources of funding, and to support the ability of investigators to generate the data needed to receive governmental or other third-party funding after the expiration of the BrightFocus award. BrightFocus’ awards, therefore, are biased towards junior investigators with new laboratories and projects, or more established investigators with particularly innovative projects.

Eligibility details

PI must be a tenure- or non-tenure track investigator of any career stage who is appropriately trained to lead an independent research study
Postdoctoral Fellows are not eligible to serve as PI for Alzheimer's Disease Research (ADR) Standard Awards
Investigators who are part of a laboratory with a current award in the same program are ineligible for concurrent awards in that program. However, it is permissible to have two concurrent awards in separate disease programs (e.g., Alzheimer's Disease Research and Macular Degeneration Research). There is no restriction on collaborators or consultants holding awards.

A full application should be submitted through the BrightFocus SmartSimple portal by October 18, 2017. Additional information can be found on the BrightFocus grants page.

If you have questions or if you plan to submit multiple applications from the same lab, please contact Amy Martinez (615-875-0740), Program Manager in the Office of Research.